Active	Status	Sponsor type	Region	Phase	Filter
7 Active 0 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wu, Tong
NCT05525637: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder	Recruiting	3	1041	RoW	YZJ-1139 20mg, YZJ-1139 40mg, Placebo	Shanghai Haiyan Pharmaceutical Technology Co., Ltd.	Insomnia Disorder	12/24	12/24
Lu, Quanyi
NCT05236621: A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma	Active, not recruiting	3	85	RoW	Pomalidomide, Dexamethasone	Qilu Pharmaceutical Co., Ltd.	Multiple Myeloma, Recurrent or Refractory	06/22	12/23
NCT06004856: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia	Recruiting	3	195	RoW	Orelabrutinib, Placebo	Beijing InnoCare Pharma Tech Co., Ltd.	Chronic Primary Immune Thrombocytopenia (ITP)	12/25	04/26